Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Money

Report suggests astaxanthin market @ $2.57 billion by 2025

August 6, 2017
AlgaeIndustryMagazine.com

The global astaxanthin market is expected to reach USD $2.57 billion by 2025, according to a new report by Grand View Research, Inc. Image: ohaskin.com

Adoption of advanced technologies in various stages of natural astaxanthin production, such as microalgae harvesting, cultivation, extraction, and drying, have been major factors driving astaxanthin’s market growth, expected to reach USD $2.57 billion by 2025. The new report, by Grand View Research, Inc., notes that awareness about health benefits, safety, and potential uses of astaxanthin is another driving force.

A rising geriatric population is estimated to result in an increase in the demand for cosmetics such as anti-ageing creams and antioxidant products for improving aesthetic appeal. Astaxanthin has been reported in many studies to possess high antioxidant and skin-friendly properties. Due to this, many cosmeceutical manufacturers and wellness spa owners are using it in new products and associated therapies, which is also estimated to drive demand.

Other findings in the report show that naturally produced astaxanthin dominated the production technology segment with a market share of 52.4% in 2016, owing to increasing awareness about its health benefits, safety, and multi-functionality.

Microalgae is estimated to be one of the largest and fastest growing natural sources, owing to increasing use of H. pluvialis for production of high-grade astaxanthin. Adoption of technologically advanced procedures for manufacturing natural astaxanthin with less contamination and maximum yield is expected to fuel market growth.

Dried algae meal or biomass held the largest market share by type of product in 2016 due to low production cost and high use in aquaculture and as animal food. Softgel capsules containing astaxanthin oil or powder are rapidly gaining acceptance as oral nutraceutical, and this is expected to fuel demand.

Based on application, aquaculture and animal feed dominated the market in 2016 with revenue of USD $220.0 million, owing to its increased usage in coloring fish and trout for quality enhancement. On the other hand, nutraceuticals are expected to witness lucrative growth over the forecast period due to factors such as high nutritional value, antioxidant properties, and low adverse effects.

North America held the largest market share by region in 2016. Key factors for that can be attributed to its dominance are: the local presence of key manufacturers, an increasing population base of health-consciousness, and a flourishing nutraceutical industry.

Supportive government regulations, growth in population with nutritional deficiencies, and increasing liquidity in developing countries are key drivers anticipated to provide high growth opportunities to the Asia Pacific region.

Read More

More Like This…

Copyright ©2010-2020 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Mazda is currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promote the wide-spread adoption of...
Susan Kraemer writes in solarpaces.org that to use solar thermal energy to convert farmed algae to fuel, the solar fuels research team at Australian National University (...
Hayley Dunning writes from the Imperial College of London that a new discovery has changed our understanding of the basic mechanism of photosynthesis and should rewrite t...
Jack Perry reports for the (Rhode Island) Providence Journal that Matthew Bertin, an assistant professor of biomedical and pharmaceutical sciences at University of Rhode ...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
John Cumbers and Kevin Costa report for Forbes that Berkeley-based biotech startup Checkerspot has announced a partnership with Gore — the makers of Gore-Tex — to use syn...
Researchers at the University of California San Diego and the University of Cambridge have 3D printed coral-inspired structures that are capable of growing dense populati...
Bloomberg News reports that a newly approved Chinese drug for Alzheimer’s will start clinical trials in the U.S. and Europe this year as the country’s first novel therapy...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
Amy Thompson writes in Space.com that SpaceX successfully launched its 15th Space Station cargo-resupply mission on Friday, June 29; carrying a payload of experiments des...
Reebok has introduced a plant-based shoe that is in class with the best performance running sneakers on the market. The Forever Floatride GROW is the latest example of Re...